Literature DB >> 3128279

500 MHz 1H n.m.r. of oligosaccharides of N-acetyl-lactosamine-type released from human erythrocyte glycopeptides by endo-beta-galactosidase.

E F Hounsell1, J Feeney, P Scudder.   

Abstract

500 MHz 1H n.m.r. spectroscopy has been used in structural studies of three linear and five branched oligosaccharides of N-acetyl-lactosamine-type that were released from desialylated blood group O erythrocyte glycopeptides by treatment with the endo-beta-galactosidase of Bacteroides fragilis followed by reduction. The following oligosaccharide alditols were characterized: (formula; see book)

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3128279      PMCID： PMC1148807          DOI： 10.1042/bj2500009

Source DB:  PubMed          Journal:  Biochem J        ISSN： 0264-6021            Impact factor:   3.857


  19 in total

1.  [Does aortocoronary bypass encourage a return to work?].

Authors:  P David; H David
Journal:  Ann Cardiol Angeiol (Paris)       Date:  1979-12

2.  Cell surface modification by endo-beta-galactosidase. Change of blood group activities and release of oligosaccharides from glycoproteins and glycosphingolipids of human erythrocytes.

Authors:  M N Fukuda; M Fukuda; S Hakomori
Journal:  J Biol Chem       Date:  1979-06-25       Impact factor: 5.157

3.  Characterisation of oligosaccharides released from human-blood-group O erythrocyte glycopeptides by the endo-beta-galactosidase of Bacteroides fragilis. A study of the enzyme susceptibility of branched poly(N-acetyllactosamine) structures.

Authors:  P Scudder; A M Lawson; E F Hounsell; R A Carruthers; R A Childs; T Feiz
Journal:  Eur J Biochem       Date:  1987-11-02

4.  Erythrocyte receptors for Mycoplasma pneumoniae are sialylated oligosaccharides of Ii antigen type.

Authors:  L M Loomes; K Uemura; R A Childs; J C Paulson; G N Rogers; P R Scudder; J C Michalski; E F Hounsell; D Taylor-Robinson; T Feizi
Journal:  Nature       Date:  1984 Feb 9-15       Impact factor: 49.962

5.  Endo-beta-D-galactosidases of Bacteroides fragilis and Escherichia freundii hydrolyze linear but not branched oligosaccharide domains of glycolipids of the neolacto series.

Authors:  P Scudder; P Hanfland; K Uemura; T Feizi
Journal:  J Biol Chem       Date:  1984-05-25       Impact factor: 5.157

6.  Structure of fetal lactosaminoglycan. The carbohydrate moiety of Band 3 isolated from human umbilical cord erythrocytes.

Authors:  M Fukuda; A Dell; M N Fukuda
Journal:  J Biol Chem       Date:  1984-04-25       Impact factor: 5.157

7.  Structure of branched lactosaminoglycan, the carbohydrate moiety of band 3 isolated from adult human erythrocytes.

Authors:  M Fukuda; A Dell; J E Oates; M N Fukuda
Journal:  J Biol Chem       Date:  1984-07-10       Impact factor: 5.157

8.  Primary-structure determination of fourteen neutral oligosaccharides derived from bronchial-mucus glycoproteins of patients suffering from cystic fibrosis, employing 500-MHz 1H-NMR spectroscopy.

Authors:  H Van Halbeek; L Dorland; J F Vliegenthart; W E Hull; G Lamblin; M Lhermitte; A Boersma; P Roussel
Journal:  Eur J Biochem       Date:  1982-09

9.  A computerized approach to the analysis of oligosaccharide structure by high-resolution proton n.m.r.

Authors:  E F Hounsell; D J Wright; A S Donald; J Feeney
Journal:  Biochem J       Date:  1984-10-01       Impact factor: 3.857

10.  Species differences in the expression of carbohydrate differentiation antigens on mammalian blood cells revealed by immunofluorescence with monoclonal antibodies.

Authors:  S J Thorpe; T Feizi
Journal:  Biosci Rep       Date:  1984-08       Impact factor: 3.840
View more
  2 in total

Review 1.  Carbohydrate analysis of glycoproteins. A review.

Authors:  K B Lee; D Loganathan; Z M Merchant; R J Linhardt
Journal:  Appl Biochem Biotechnol       Date:  1990-01       Impact factor: 2.926

2.  Single mid-chain GlcNAc beta 1-6Gal beta 1-4R sequences of linear oligosaccharides are resistant to endo-beta-galactosidase of Bacteroides fragilis.

Authors:  O Renkonen; L Penttilä; R Niemelä; A Leppänen
Journal:  Glycoconj J       Date:  1991-08       Impact factor: 2.916
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.